Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 285, Issue 4, pp 301–313 | Cite as

Interaction of prostaglandins and indomethacin with algesic substances

  • F. Lembeck
  • H. Juan


  1. 1.

    The isolated perfused rabbit ear connected to the body by its nerve only was used to investigate the modification of the algesic effect of bradykinin, substance P and acetylcholine (ACh) by indomethacin.

  2. 2.

    The effect of these algesic substances was inhibited by indomethacin in proportion to the dose and duration of infusion.

  3. 3.

    The factors by which the algesic effect was reduced by indomethacin and the factors by which it was enhanced by prostaglandin E1 were found to be correlated. The factors were greatest for bradykinin, intermediate for substance P and smallest for ACh, thus showing that the algesic effect of bradykinin is most dependent on the presence of prostaglandin E1.

  4. 4.

    In the presence of additional amounts of prostaglandin E1, indomethacin was able to reduce the algesic effect of bradykinin and ACh to some extent. This cannot be explained by blockade of the PG synthesis.

  5. 5.

    The vasoconstriction found after i.a. injection of bradykinin, substance P and PGF was partly inhibited by indomethacin. This was explained by a direct inhibitory influence of indomethacin on the vasoconstrictor effect of the prostaglandin or the algesic substances.

  6. 6.

    Indomethacin, due to a direct and reversible antagonism, reduced the contraction of the isolated guinea-pig ileum induced by PGE2 more than the contraction induced by bradykinin.

  7. 7.

    It is confirmed that indomethacin acts mainly by inhibition of biosynthesis of prostaglandins. An additional direct inhibition of prostaglandin-actions by indomethacin can, however, be seen under certain experimental conditions.


Key words

Pain Response Prostaglandins Bradykinin Substance P Acetylcholine Indomethacin 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aiken, J. W., Vane, J. R.: Blockade of angiotensin-induced prostaglandin release from dog kidney by indomethacin. Pharmacologist 13, 564 (1971)Google Scholar
  2. Al Tai, S. A., Graham, J. D. P.: The actions of prostaglandins E1 and F on the perfused vessels of the isolated rabbit ear. Brit. J. Pharmacol. 44, 699–710 (1972)Google Scholar
  3. Collier, H. O. J., Schneider, C.: Nociceptive response to prostaglandins and analgesic actions of aspirin and morphine. Nature New Biol. 236, 141–143 (1972)Google Scholar
  4. Collier, H. O. J., Sweatman, W. J. F.: Antagonism by fenamates of prostaglandin F and of slow reacting substance on human bronchial muscle. Nature (Lond.) 219, 864–865 (1968)Google Scholar
  5. Crunkhorn, P., Willis, A. L.: Cutaneous reactions to intradermal prostaglandins. Brit. J. Pharmacol. 41, 49–56 (1971).Google Scholar
  6. Ferreira, S. H.: Prostaglandins, aspirin-like drugs and analgesia. Nature New Biol. 240, 200–203 (1972)Google Scholar
  7. Ferreira, S. H., Moncada, S., Vane, J. R.: Indomethacin and aspirin abolish prostaglandin release from the spleen. Nature New Biol. 231, 237–239 (1971)Google Scholar
  8. Ferreira, S. H., Moncada, S., Vane, J. R.: Some effects of inhibiting endogenous prostaglandin formation on the response of the cat spleen. Brit. J. Pharmacol. 47, 48–58 (1973)Google Scholar
  9. Ferreira, S. H., Moncada, S., Vane, J. R.: Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs. Brit. J. Pharmacol. 49, 86–97 (1973a)Google Scholar
  10. Ferreira, S. H., Moncada, S., Vane, J. R.: Potentiation by prostaglandins of the nociceptive activity of bradykinin in the dog knee joint. Brit. J. Pharmacol. 50, 461 P (1974)Google Scholar
  11. Freeman, P. C., West, G. B.: Skin reactions to prostaglandins. J. Pharm. Pharmacol. 24, 407–408 (1972)Google Scholar
  12. Juan, H., Lembeck, F.: Influence of prostaglandin E1, indomethacin, calcium and potassium on the action of nociceptive substances. Naunyn-Schmiedeberg's Arch. Pharmacol. 282, R42 (1974)Google Scholar
  13. Juan, H., Lembeck, F.: Action of peptides and other algesic agents on paravascular pain receptors of the isolated perfused rabbit ear. Naunyn-Schmiedeberg's Arch. Pharmacol. 283, 151–164 (1974a)Google Scholar
  14. Kaley, G., Weiner, R.: Prostaglandin E1: a potential mediator of the inflammatory response. Ann. N.Y. Acad. Sci. 180, 338–350 (1971)Google Scholar
  15. Lembeck, F., Geipert, F., Starke, K.: Sialogene Wirkung von Peptiden bei Hühnern. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 261, 422–433 (1968)Google Scholar
  16. Lim, R. K. S., Guzman, F., Rodgers, D. W., Goto, K., Braun, C., Dickerson, G. D., Engle, R. J.: Site of action of narcotic and non-narcotic analgesics determined by blocking bradykinin-evoked visceral pain. Arch. int. Pharmacodyn. 152, 25–58 (1964)Google Scholar
  17. McGiff, J. C., Terragno, N. A., Malik, K. U., Lonigro, A. J.: Release of a prostaglandin E-like substance from canine kidney by bradykinin. Circulat. Res. 31, 36–43 (1972)Google Scholar
  18. Milton, A. S.: Prostaglandin E1 and endotoxin fever, and the effects of aspirin, indomethacin, and 4-acetamido-phenol. Advances Biosci. 9, 495–500 (1973)Google Scholar
  19. Northover, B. J.: The effect of anti-inflammatory drugs on vascular smooth muscle. Brit. J. Pharmacol. 31, 483–493 (1967)Google Scholar
  20. Northover, B. J.: The effect of drugs on the constriction of isolated depolarized blood vessels in response to calcium or barium. Brit. J. Pharmacol. 34, 417–428 (1968)Google Scholar
  21. Northover, B. J.: Effect of anti-inflammatory drugs on the binding of calcium to cellular membranes in various human and guinea-pig tissues. Brit. J. Pharmacol. 48, 496–504 (1973)Google Scholar
  22. Peskar, B., Hertting, G.: Release of prostagandins from isolated cat spleen by angiotensin and vasopressin. Naunyn-Schmiedeberg's Arch. Pharmacol. 279, 227–234 (1973)Google Scholar
  23. Rosenthale, M. E., Dervinis, A., Kassarich, J., Singer, S.: Prostaglandins and anti-inflammatory drugs in the dog knee joint. J. Pharm. Pharmacol. 24, 149–150 (1972)Google Scholar
  24. Smith, J. B., Willis, A. L.: Aspirin selectively inhibits prostaglandin production in human platelets. Nature New Biol. 231, 235–237 (1971)Google Scholar
  25. Takeguchi, C., Sih, C. J.: A rapid spectrophotometric assay for prostaglandin synthetase: application to the study of non-steroidal anti-inflammetory agents. Prostaglandins 2, 169–184 (1972)Google Scholar
  26. Vane, J. R.: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol. 231, 232–235 (1971)Google Scholar
  27. Vane, J. R.: Inhibition of prostaglandin biosynthesis as the mechanism of action of aspirinlike drugs. Advances Biosci. 9, 395–411 (1973)Google Scholar
  28. Vane, J. R., Williams, K. I.: The contribution of prostaglandin production to contractions of the isolated uterus of the rat. Brit. J. Pharmacol. 48, 629–639 (1973)Google Scholar

Copyright information

© Springer-Verlag 1974

Authors and Affiliations

  • F. Lembeck
    • 1
  • H. Juan
    • 1
  1. 1.Institut für Experimentelle und Klinische Pharmakologie der Universität GrazGrazAustria

Personalised recommendations